Mon, December 5, 2022
Sun, December 4, 2022
Fri, December 2, 2022
Thu, December 1, 2022
Wed, November 30, 2022
Tue, November 29, 2022
Mon, November 28, 2022
Fri, November 25, 2022
Thu, November 24, 2022
Wed, November 23, 2022

Michael Yee Maintained (BIIB) at Strong Buy with Increased Target to $350 on, Nov 30th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-350-on-nov-30th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Michael Yee of Jefferies, Maintained "Biogen Inc." (BIIB) at Strong Buy with Increased Target from $325 to $350 on, Nov 30th, 2022.

Michael has made no other calls on BIIB in the last 4 months.



There are 18 other peers that have a rating on BIIB. Out of the 18 peers that are also analyzing BIIB, 4 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Yatin Suneja of "Guggenheim" Maintained at Hold with Increased Target to $270 on, Friday, November 11th, 2022
  • Steve Chesney of "Atlantic Equities" Maintained at Hold with Increased Target to $220 on, Wednesday, October 26th, 2022
  • Chris Schott of "JP Morgan" Maintained at Hold with Increased Target to $275 on, Friday, September 30th, 2022
  • Christopher Raymond of "Piper Sandler" Maintained at Hold with Increased Target to $280 on, Wednesday, September 28th, 2022


These are the ratings of the 14 analyists that currently disagree with Michael


  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $350 on, Tuesday, November 15th, 2022
  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $315 on, Monday, November 14th, 2022
  • Salim Syed of "Mizuho" Maintained at Strong Buy with Increased Target to $325 on, Tuesday, November 1st, 2022
  • Salveen Richter of "Goldman Sachs" Upgraded from Hold to Strong Buy and Held Target at $370 on, Wednesday, October 26th, 2022
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $310 on, Wednesday, October 26th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $325 on, Wednesday, October 26th, 2022
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $325 on, Wednesday, October 26th, 2022
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $331 on, Wednesday, October 26th, 2022
  • Paul Matteis of "Stifel" Upgraded from Hold to Strong Buy and Held Target at $299 on, Thursday, October 13th, 2022
  • Jasper Hellweg of "Argus Research" Upgraded from Hold to Strong Buy on, Friday, October 7th, 2022
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $309 on, Thursday, October 6th, 2022
  • Brian Skorney of "Baird" Upgraded from Hold to Buy and Increased Target to $340 on, Wednesday, September 28th, 2022
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $350 on, Wednesday, September 28th, 2022
  • Evan Seigerman of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $360 on, Wednesday, September 28th, 2022

Publication Contributing Sources